Home » Drug Information » FDA-Approved Drugs » 1997
Medical Areas: Cardiology/Vascular Diseases | Endocrinology
View By: Year Company Therapeutic Areas Drug Names
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: SmithKline Beecham
Approval Status: Approved December 1997
Treatment Area: hypertension
Teveten was approved for the treatment of hypertension, as
either a monotherapy or for use in combination with other
antihypertensives.
Teveten is an angiotensin II antagonist.
